The European Commission’s two stakeholder consultations on the Revision of the Blood, Tissue and Cells (BTC) Directive closed on the 15^th of April 2021. The public consultation provided an opportunity to give feedback on policy options proposed by the Commission to address gaps in the existing Directive. A total of 214 stakeholders replied to the general consultation, and 160 organisations replied to the targeted consultation. Stakeholder input is  currently being analysed by the European Commission, and a report will soon be available. Further, a first external study has been initiated to support the Impact Assessment, and will be led by a team of three BTC experts. The publication of the Commission’s Impact Assessment is expected at the end of 2021, alongside the proposal. More information can be found here.